Michael L. Pearl MD

Obstetrics & Gynecology•Lebanon, NH

Gynecologic Oncology, Hospice & Palliative Medicine

Professor of Obstetrics & Gynecology, SUNY Stony Brook

Join to View Full Profile

1 Medical Center DrLebanon, NH 03756
Phone+1 603-650-5000

Education & Training

University of MichiganFellowship, Gynecologic Oncology, 1991 - 1994
University of California (San Francisco)Residency, Obstetrics and Gynecology, 1986 - 1990
University of California San Francisco School of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1988 - Present
NY State Medical License 1994 - 2026
NH State Medical License 2023 - 2025
MI State Medical License 1991 - 1995
HI State Medical License 1988 - 1992
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2008-2014
Newsday - Top Doctors on Long Island Castle Connolly, 2008, 2010-2014
Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
ACTIVE_NOT_RECRUITING
PHASE3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
The International Gynecologic Cancer Society consensus statement on palliative care.
Keiichi Fujiwara, Stephen R Connor, Noriko Fujiwara, Raimundo Correa, Anisa Mburu
International Journal of Gynecological Cancer. 2024-08-05
4 citations
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic...
Ian S Hagemann, Wei Deng, Richard J Zaino, Matthew A Powell, Camille Gunderson Jackson
Gynecologic Oncology. 2023-10-01
5 citations
Palliative care in gynecologic oncology: a narrative review of current literature and vision for the future.
Chelsea Salyer, Ramey D Littell, Michael L Pearl, Alaina J Brown, Shaundra Popowich
Annals of Palliative Medicine. 2022-11-01

Journal Articles

Endometrial Carcinoma Recurrence According to Race and Ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study
M L Pearl, D S Miller, W T Creasman, P H Thaker, J F Boggess, S R Guntupalli, D G Mutch, J L Walker, O B Ioffe, D E Cohn, L S Downs, International Journal of Cancer